Evidence map›Paper›PMID 31779928›Full record

ArticleJACC. Heart failure2019

Impact of Age on Comorbidities and Outcomes in Heart Failure With Reduced Ejection Fraction.

Jessica A Regan, Dalane W Kitzman, Eric S Leifer, William E Kraus, Jerome L Fleg, Daniel E Forman, David J Whellan, Daniel Wojdyla, Kishan Parikh, Christopher M O'Connor and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in JACC. Heart failure, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00047437 (Heart Failure), which is not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00047437 phase3completednot on this map

Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)

TypeinterventionalSponsorDuke UniversityRan2003 to 2008Enrolled2,331ConditionsCardiovascular Diseases, Heart Diseases, Heart Failure, CongestiveArmsSupervised Exercise Training Program
3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Trial
  2. Prevalence and prognosis of multimorbidity in heart failure with mildly reduced ejection fraction.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Jessica A ReganDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina. Electronic address: jessica.a.regan@duke.edu.
Dalane W KitzmanDepartment of Internal Medicine, Section on Cardiovascular Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Eric S LeiferNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
William E KrausDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
Jerome L FlegNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Daniel E FormanDepartment of Medicine, University of Pittsburgh and Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.
David J WhellanDepartment of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.
Daniel WojdylaDuke Clinical Research Institute, Durham, North Carolina.
Kishan ParikhDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
Christopher M O'ConnorInova Heart and Vascular Institute, Falls Church, Virginia.
Robert J MentzDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.

Funding

VARIABILITY, STABILITY & SMOOTHNESS OF WALKINGP30AG024827 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JENNIFER S BRACH · 2004 to 2026
$28.6M
Investigating Gains in Neurocognition in an Intervention Trial of Exercise SupplementR01AG053952 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BURNS, JEFFREY MURRAY, ERICKSON, KIRK I · 2016 to 2020
$27.5M
Molecular Transducers of Physical Activity Consortium Adult Clinical CenterU01AR071130 · NIAMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI MUSI, NICOLAS, RASMUSSEN, BLAKE B · 2017 to 2024
$17.7M
TRANSFORM-HF CCCU01HL125511 · NHLBI · YALE UNIVERSITY · PI MENTZ, ROBERT JOHN, VELAZQUEZ, ERIC J · 2017 to 2021
$7.7M
REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure PatientsR01AG045551 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KITZMAN, DALANE W · 2014 to 2018
$6.8M
Pepper OAIC Coordinating CenterU24AG059624 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DALANE W KITZMAN · 2018 to 2026
$6.0M
Modified Application of Cardiac Rehabilitation (CR) for Older Adults (MACRO)R01AG060499 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FORMAN, DANIEL E. · 2018 to 2022
$5.0M
A Multidisciplinary Analysis of Gelsolin Amyloid DiseaseR01AG018917 · NIA · SCRIPPS RESEARCH INSTITUTE, THE · PI KELLY, JEFFERY W · 2002 to 2010
$4.2M
Heart Failure Clinical Research Network Regional Clinical Center (U10)U10HL110312 · NHLBI · DUKE UNIVERSITY · PI FELKER, GARY M · 2012 to 2018
$3.5M
Stimulating Access to Research in Residency (StARR) - NHLBIR38HL143612 · NHLBI · DUKE UNIVERSITY · PI Mai ElMallah, David H. Harpole · 2018 to 2026
$2.6M
Nitrite therapy to improve mitochondrial energetics and physical activity in older adultsR01AG058883 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FORMAN, DANIEL E. · 2019 to 2021
$2.0M
ACTION - A CHF Trial Investigating Outcomes of ExerciseU01HL064250 · NHLBI · HENRY FORD HEALTH SYSTEM · PI KETEYIAN, STEVEN J · 2002 to 2007
$1.4M
NHLBI NIH HHS R38 HL143612NHLBI NIH HHS U01 HL064250NHLBI NIH HHS U01 HL064265NHLBI NIH HHS U01 HL125511NHLBI NIH HHS U10 HL110312NIAMS NIH HHS U01 AR071130NIA NIH HHS P30 AG024827NIA NIH HHS R01 AG018917NIA NIH HHS R01 AG045551NIA NIH HHS R01 AG053952NIA NIH HHS R01 AG058883NIA NIH HHS R01 AG060499NIA NIH HHS U24 AG059624
6 · The paper itself

Abstract

objectivesThis study sought to determine whether age modifies the impact of key comorbidities on clinical outcomes for patients with heart failure with reduced ejection fraction (HFrEF).

backgroundComorbidities impact outcomes in HFrEF. However, the effect of age on the impact of comorbidities on prognosis is not clearly understood.

methodsCox proportional hazards models were used assessed interactions between age and comorbidities on the primary composite endpoint (all-cause mortality or hospitalization) and secondary endpoints in the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) multicenter trial of 2,331 patients with HFrEF.

resultsAge did not significantly modify the effect of any comorbidity on the primary endpoint. However, age significantly modified the effect of body mass index (BMI) on all-cause mortality (interaction p = 0.02). Among patients ≥70 years of age, there was a U-shaped relationship between BMI and 1-year mortality, where BMI of 20 kg/m

conclusionsIn chronic HFrEF, age markedly altered the impact of BMI and depressive symptoms on all-cause mortality, with much higher risk in older patients, but was not as strong a predictor of mortality/hospitalizations as cumulative comorbidity score. (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION]; NCT00047437).

Indexed as

AgedAge FactorsCause of DeathFemaleHeart FailureHospitalizationHumansMaleMiddle AgedPrognosisStroke Volumeagebody mass indexcomorbiditiesdepressionheart failure with reduced ejection fraction

Identifiers

PMID31779928
PMCPMC6936107

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.